Xeris Biopharma Holdings, Inc.
Ticker: 1867096
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 92.10+10.8% | 83.13+11.8% | 74.38+4.0% | 71.54+19.0% | 60.12+10.8% | 54.27+12.9% | 48.07+18.3% | 40.64 |
| Total Income | 92.10+10.8% | 83.13+11.8% | 74.38+4.0% | 71.54+19.0% | 60.12+10.8% | 54.27+12.9% | 48.07+18.3% | 40.64 |
| EXPENSES | ||||||||
| Expenditure | 86.93+15.6% | 75.21+11.2% | 67.65+0.9% | 67.06+6.1% | 63.21-5.9% | 67.16+19.4% | 56.25+2.5% | 54.88 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00+100.0% | -3.32-542.7% | 0.75+141.9% | 0.31 |
| PROFIT | ||||||||
| Net Profit | -31.10-1494.6% | 2.23+259.7% | 0.62+132.1% | -1.93+79.1% | -9.22+41.4% | -15.74-4.9% | -15.01+20.9% | -18.98 |
| KEY METRICS | ||||||||
| OPM % | 5.62%-3.91pp | 9.52%+0.47pp | 9.05%+2.78pp | 6.26%+11.40pp | -5.14%+18.62pp | -23.76%-6.72pp | -17.03%+18.02pp | -35.05% |
| NPM % | -33.77%-36.46pp | 2.69%+1.85pp | 0.83%+3.53pp | -2.69%+12.64pp | -15.34%+13.67pp | -29.00%+2.22pp | -31.22%+15.49pp | -46.70% |
| EPS | -0.18-1900.0% | 0.01 | 0.00+100.0% | -0.01+83.3% | -0.06+45.5% | -0.11-10.0% | -0.10+28.6% | -0.14 |
Corporate Events
Board MeetingXERS
202629Jun
Board Meeting
Board of Directors changes: Appointment of Nerissa Kreher, M…
SEC Filing ↗